Informations générales (source: ClinicalTrials.gov)
Strategy for Transfer to Emergency Head And Neck (UTEC) of Stroke Alerts With Suspicion of Large Vessel Occlusion for Mechanical Thrombectomy in the Languedoc Roussillon Region (START)
Observational
University Hospital, Montpellier (Voir sur ClinicalTrials)
octobre 2019
juin 2022
29 juin 2024
A mono-centre observational study with the aim of compare clinical outcome at 3 month on
patients admitted with recent cerebral infarct and intracranial large vessel occlusion in
the anterior circulation who are eligible for mechanical thrombectomy in three different
position : Patients admitted first in the Comprehensive Stroke Center of Montpellier,
those transferred after Proximity Stroke Unit or prehospital bypass for patients with
high suspicion of large vessel occlusion.to the Comprehensive Stroke Center of
Montpellier
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Gui De Chauliac Hospital - 34295 - Montpellier - France | Caroline ARQUIZAN, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
1. Patient, admitted to the Emergency Department Head and Neck of the CHU de
Montpellier, over 18 years old, without limit of upper age
2. With TIA or cerebral infarction (confirmed by brain imaging (MRI or CT scan), acute
(Time of stroke symptoms or discovery of patient ≤ 12 h)
3. With anterior circulation intracranial large vessel occlusion (M1, T or proximal
M2), confirmed by arterial imaging (magnetic resonance angiography-MRA- or
angioscanner)
4. No objection of the patient or their representative to being included in the cohort
1. Patient, admitted to the Emergency Department Head and Neck of the CHU de
Montpellier, over 18 years old, without limit of upper age
2. With TIA or cerebral infarction (confirmed by brain imaging (MRI or CT scan), acute
(Time of stroke symptoms or discovery of patient ≤ 12 h)
3. With anterior circulation intracranial large vessel occlusion (M1, T or proximal
M2), confirmed by arterial imaging (magnetic resonance angiography-MRA- or
angioscanner)
4. No objection of the patient or their representative to being included in the cohort
1. Patient with severe intercurrent pathology impacting the short-term vital prognosis
and making follow-up impossible
2. Predictable impossibility of patient follow-up